A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
Clinical trial NCT01473407 · COMPLETED
Trial details
- NCT number
- NCT01473407
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-31
- Primary completion
- 2014-02-11
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.